Share on StockTwits

Vectura Group PLC (LON:VEC)‘s stock had its “hold” rating reaffirmed by equities researchers at N+1 Singer in a research report issued on Tuesday. They currently have a GBX 135 ($2.26) price target on the stock. N+1 Singer’s target price suggests a potential downside of 5.59% from the stock’s previous close.

A number of other firms have also recently commented on VEC. Analysts at FinnCap reiterated a “buy” rating on shares of Vectura Group PLC in a research note on Thursday, July 17th. They now have a GBX 202 ($3.38) price target on the stock. Separately, analysts at Oriel Securities Ltd reiterated a “buy” rating on shares of Vectura Group PLC in a research note on Thursday, July 17th. They now have a GBX 207 ($3.46) price target on the stock. Finally, analysts at Canaccord Genuity reiterated a “buy” rating on shares of Vectura Group PLC in a research note on Monday, June 30th. They now have a GBX 192 ($3.21) price target on the stock. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of GBX 178 ($2.98).

Vectura Group PLC (LON:VEC) opened at 143.00 on Tuesday. Vectura Group PLC has a 52-week low of GBX 94.25 and a 52-week high of GBX 171.50. The stock’s 50-day moving average is GBX 139.6 and its 200-day moving average is GBX 142.7. The company’s market cap is £571.8 million.

Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.

Receive News & Ratings for Vectura Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.